产品说明书

AER-271

Print
Chemical Structure| 634913-39-6 同义名 : -
CAS号 : 634913-39-6
货号 : A1158762
分子式 : C15H9ClF6NO5P
纯度 : 99%+
分子量 : 463.653
MDL号 : N/A
存储条件：

粉末 Sealed in dry,Room Temperature

液体 -20°C:3-6个月-80°C:12个月
溶解度 :

DMSO: 120 mg/mL(258.81 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO
动物实验配方：
生物活性
描述 AER-271 is a phosphonate prodrug derivative of AER-270, an AQP4 inhibitor used in acute ischaemic stroke studies. AER-271 is converted to AER-270 in vivo by endogenous phosphatases[1].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.16mL

0.43mL

0.22mL

10.78mL

2.16mL

1.08mL

21.57mL

4.31mL

2.16mL
参考文献

[1]Wallisch JS, et al. The aquaporin-4 inhibitor AER-271 blocks acute cerebral edema and improves early outcome in a pediatric model of asphyxial cardiac arrest. Pediatr Res. 2019 Mar;85(4):511-517.

[2]Farr GW, et al. Functionalized Phenylbenzamides Inhibit Aquaporin-4 Reducing Cerebral Edema and Improving Outcome in Two Models of CNS Injury. Neuroscience. 2019 Apr 15;404:484-498.